Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/4/20 18:41 | 1/31/20 | NTEC | Health | Drug | Pharmaceutical Preparations | Dexcel Pharma Technologies Ltd. | L3 | T | S.m | -282 | 0.3075 | 0 | -916 | -18 | 4,235 | D | |||||||||||||||
11/21/19 17:00 | 11/19/19 | NTEC | Health | Drug | Pharmaceutical Preparations | Silberman Issac | L3 | D | S | -1 | 0.5040 | 0 | -1 | -20 | 4 | D | |||||||||||||||
8/29/19 16:16 | 8/28/19 | NTEC | Health | Drug | Pharmaceutical Preparations | Meckler Jeffrey A | L3 | DO | CEO | P | 14 | 0.6810 | 0 | 20 | 11 | 197 | D | ||||||||||||||
8/29/19 16:16 | 8/27/19 | NTEC | Health | Drug | Pharmaceutical Preparations | Maddaluna Anthony J | L3 | D | P | 12 | 0.4700 | 0 | 25 | 88 | 54 | D | |||||||||||||||
8/27/19 16:20 | 8/23/19 | NTEC | Health | Drug | Pharmaceutical Preparations | Kozarich John W | L3 | D | P | 46 | 0.4590 | 0 | 100 | 193 | 152 | D | |||||||||||||||
8/27/19 16:18 | 8/23/19 | NTEC | Health | Drug | Pharmaceutical Preparations | Meckler Jeffrey A | L3 | DO | CEO | P | 46 | 0.4570 | 0 | 100 | 130 | 177 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |